Personalized Medical Devices Market: By Therapeutic Area (Neurology, Oncology, Cardiology, Psychiatry, Antiviral, Others) By Application (Companion Diagnostics, Biomarker identification, Health Informatics, Clinical Research), By End User(Hospitals, Molecular Diagnostic Laboratories and Testing facilities, Homecare settings, Others), By Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Personalized Medical Devices Market size was valued at USD 494.1 billion in 2022 and is expected to growth at a CAGR of 6.3% 2023 to 2029. Personalized Medical Devices (PM) can possibly tailor made devices with the best reaction and most noteworthy security edge to guarantee better patient care. By empowering every patient to get prior judgments, chance appraisals, and ideal medications, Personalized Medical Devices Market holds guarantee for enhancing medicinal services while additionally bringing down expenses. Medical devices companies are encountering aggressive and taken a toll weight from various sides. On one hand, rivalry emerging from developing markets requests high-volume, straightforward gadgets with bring down costs, applying weight on costs all around. Then again, organizations confront aggressive weight from new wellsprings of medicinal gadget development like added substance fabricating, which empowers unique produce of patient-particular careful instruments and implants. Some of the examples for personalized medical devices Tinnitus masker is customized by the producer to understanding tinnitus.The tinnitus treatment custom-tailors the sound signs to suit the individual patient's listening ability necessities Pedicle screw spinal frameworks – Spinal frameworks comprising of a bar/screw/snare/connector unit are amassed by a specialist to oblige a patient's interesting life systems/physiology utilizing MRI/CT imaging. Programming based quantitative EEG investigation intended to anticipate a person's reaction to different psychotropic medications. The gadget gives the likelihood of reaction to different solutions to direct clinician in basic leadership. The Zenith Fenestrated AAA Endovascular Graft is demonstrated for the endovascular treatment of patients with stomach aortic or aortoiliac aneurysms having morphology reasonable for endovascular repair. The fenestrated gadget takes into account treatment of patients with shorter proximal neck lengths (i.e., length of solid aorta between the renal corridors and the aneurysm) when contrasted with the individuals who can be dealt with utilizing other endovascular joins. Every gadget is customized to the patient's individual aortic life structures with openings in the join material set suitably to keep up blood stream to branch vessels of the aorta. The Artificial Pancreas Device System is a gadget under clinical examination that naturally screens understanding glucose levels and conveys persistent customized insulin measurements in individuals with diabetes.

Personalized Medical Devices Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Personalized Medical Devices Market Dynamics

Personalized Medical Devices market is relied upon to witness fast development because of expanding illness occurrence and profound focal point of launching new products for tumor patients where viability has been turned out to be higher when contrasted with different treatments. Quick outcomes and tweaked impacts, bring down likelihood of prescription defects and unfriendly medication responses are a portion of alternate factors that could make reasonable footing in both R&D and income potential for these solutions. Late advancements in the pharmacogenomics are relied upon to make appropriate condition for developing devices, which are particular to one patient or gathering. Advancement of hereditary databases could give extra lift to the market. Up and coming remedial application openings in fields, for example, cardio-renal, neurology, antiviral, pneumonic, psychiatry among others could make R&D footing over all locales. High advancement costs, problematic improvement structure and between understanding changeability of impacts are a portion of the limitations that could hamper income development of the Personalized Medical Devices market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Personalized Medical Devices Market Segmentation

By Therapeutic Area
  • Neurology
  • Oncology
  • Cardiology
  • Psychiatry
  • Antiviral
  • Others
By Application
  • Companion Diagnostics
  • Biomarker identification
  • Health Informatics
  • Clinical Research
By End User
  • Hospitals
  • Molecular Diagnostic Laboratories and Testing facilities
  • Homecare settings
  • Others
By Geography
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Becton, Dickinson and Company (USA)
  • Abbott Laboratories, Inc. (USA)
  • bioMerieux, Inc. (France)
  • Biomerica, Inc.(USA)
  • Olympus Corporation (Japan)
  • Qiagen N.V. (Geramany)
  • Siemens AG (Germany)
  • Thermo Fischer Scientific, Inc. (USA).